Pharmacokinetics of ticarcillin in patients with cystic fibrosis: A controlled prospective study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1990-01

AUTHORS

Ronald Groot, Barbara D Hack, Allan Weber, Donald Chaffin, Bonnie Ramsey, Arnold L Smith

ABSTRACT

We compared the pharmacokinetics of ticarcillin at a dose of 120 mg/kg in 11 patients with cystic fibrosis to 11 control subjects matched for age and sex. The mean elimination half-life of ticarcillin in serum was 70.8 minutes in the control subjects and 53.1 minutes in the patients with cystic fibrosis. The total body clearance of ticarcillin was significantly higher in cystic fibrosis patients (65.6 +/- 22.0 versus 46.2 +/- 10.9 ml/min/m2 in control subjects; p = 0.017). The nonrenal clearance of ticarcillin was also significantly higher in patients with cystic fibrosis (24.8 +/- 11.1 versus 13.3 +/- 6.0 ml/min/m2 for the control group; p = 0.006). There was no significant difference in volume of distribution between the two groups. We concluded that the shorter elimination half-life and the higher total body clearance of ticarcillin in patients with cystic fibrosis are a result of an increase in both renal and nonrenal elimination. More... »

PAGES

73-78

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/clpt.1990.11

DOI

http://dx.doi.org/10.1038/clpt.1990.11

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036241110

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2295222


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromatography, High Pressure Liquid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cystic Fibrosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Half-Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Penicillins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ticarcillin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Groot", 
        "givenName": "Ronald", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hack", 
        "givenName": "Barbara D", 
        "id": "sg:person.01120322662.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120322662.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weber", 
        "givenName": "Allan", 
        "id": "sg:person.0740433207.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740433207.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chaffin", 
        "givenName": "Donald", 
        "id": "sg:person.0671260531.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671260531.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ramsey", 
        "givenName": "Bonnie", 
        "id": "sg:person.01303525623.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303525623.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Arnold L", 
        "id": "sg:person.01104353520.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104353520.48"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1990-01", 
    "datePublishedReg": "1990-01-01", 
    "description": "We compared the pharmacokinetics of ticarcillin at a dose of 120 mg/kg in 11 patients with cystic fibrosis to 11 control subjects matched for age and sex. The mean elimination half-life of ticarcillin in serum was 70.8 minutes in the control subjects and 53.1 minutes in the patients with cystic fibrosis. The total body clearance of ticarcillin was significantly higher in cystic fibrosis patients (65.6 +/- 22.0 versus 46.2 +/- 10.9 ml/min/m2 in control subjects; p = 0.017). The nonrenal clearance of ticarcillin was also significantly higher in patients with cystic fibrosis (24.8 +/- 11.1 versus 13.3 +/- 6.0 ml/min/m2 for the control group; p = 0.006). There was no significant difference in volume of distribution between the two groups. We concluded that the shorter elimination half-life and the higher total body clearance of ticarcillin in patients with cystic fibrosis are a result of an increase in both renal and nonrenal elimination.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/clpt.1990.11", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "name": "Pharmacokinetics of ticarcillin in patients with cystic fibrosis: A controlled prospective study", 
    "pagination": "73-78", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "aca2f56cb04d22363831fa80130641987e542af7d06bfed7cfa419a47229abac"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2295222"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/clpt.1990.11"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036241110"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/clpt.1990.11", 
      "https://app.dimensions.ai/details/publication/pub.1036241110"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000062.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1038/clpt.1990.11/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/clpt.1990.11'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/clpt.1990.11'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/clpt.1990.11'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/clpt.1990.11'


 

This table displays all metadata directly associated to this object as RDF triples.

160 TRIPLES      20 PREDICATES      41 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/clpt.1990.11 schema:about N1b85cdcc4afa4239b63fe0091c1288b8
2 N6b6a67c203bf4d7392d4452a8ba9afba
3 N86e3935c2fe743749df76f732523c4c2
4 N8876e235f6c2498cb3899eceb6c419a6
5 N8c8335c95f754b02ab37757ae3bdc7ca
6 N996f087638104a83941a0662f9ccc5ea
7 Nb08970654629462e8a342111d274ea89
8 Nc0f94e2ed4284a5db1f1ef9d909f6008
9 Nc5ebec121afa4ba2877415968ca8ef04
10 Ndc3c8dd407a541f4ada60da54b27bddf
11 Nf6355e0ad38f41babf31b72f26a58700
12 Nf6d363eaa15344168fa03626451b91d3
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author Nda24dbc038d240deac3bac81a3076e76
16 schema:datePublished 1990-01
17 schema:datePublishedReg 1990-01-01
18 schema:description We compared the pharmacokinetics of ticarcillin at a dose of 120 mg/kg in 11 patients with cystic fibrosis to 11 control subjects matched for age and sex. The mean elimination half-life of ticarcillin in serum was 70.8 minutes in the control subjects and 53.1 minutes in the patients with cystic fibrosis. The total body clearance of ticarcillin was significantly higher in cystic fibrosis patients (65.6 +/- 22.0 versus 46.2 +/- 10.9 ml/min/m2 in control subjects; p = 0.017). The nonrenal clearance of ticarcillin was also significantly higher in patients with cystic fibrosis (24.8 +/- 11.1 versus 13.3 +/- 6.0 ml/min/m2 for the control group; p = 0.006). There was no significant difference in volume of distribution between the two groups. We concluded that the shorter elimination half-life and the higher total body clearance of ticarcillin in patients with cystic fibrosis are a result of an increase in both renal and nonrenal elimination.
19 schema:genre research_article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf Naf6fe96f59eb421a880aee55931c81fe
23 Nba516bda2d6748149241fcb456bb6910
24 sg:journal.1017409
25 schema:name Pharmacokinetics of ticarcillin in patients with cystic fibrosis: A controlled prospective study
26 schema:pagination 73-78
27 schema:productId N0380e5e3261a4aafa06e5b78067b38fa
28 N0b706e1ab0514937998f6d76ac6a1c83
29 N28bdbd22672f40b1a7be68d02f55b425
30 Na9e5c4d408de4085908e3a59f7fa62f6
31 Nb28147f60d5c41768cd21e3c75ca507e
32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036241110
33 https://doi.org/10.1038/clpt.1990.11
34 schema:sdDatePublished 2019-04-10T21:59
35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
36 schema:sdPublisher N66ea2ebbf40446ea828bc3c6b4a96d4b
37 schema:url http://onlinelibrary.wiley.com/doi/10.1038/clpt.1990.11/abstract
38 sgo:license sg:explorer/license/
39 sgo:sdDataset articles
40 rdf:type schema:ScholarlyArticle
41 N005ad90069c54724b7e075d5f73edf9d rdf:first sg:person.0740433207.38
42 rdf:rest N43de1bed3c674ffa9a62bb991514f88f
43 N0380e5e3261a4aafa06e5b78067b38fa schema:name dimensions_id
44 schema:value pub.1036241110
45 rdf:type schema:PropertyValue
46 N0b706e1ab0514937998f6d76ac6a1c83 schema:name nlm_unique_id
47 schema:value 0372741
48 rdf:type schema:PropertyValue
49 N172bd7b7933041cf9ef984a80d9e49b8 schema:name University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center
50 rdf:type schema:Organization
51 N1b85cdcc4afa4239b63fe0091c1288b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Male
53 rdf:type schema:DefinedTerm
54 N2802ea92bcca4fdf877fa55d4e9325a9 schema:affiliation N6dbd197dbd474e75afb62cb1442347c4
55 schema:familyName Groot
56 schema:givenName Ronald
57 rdf:type schema:Person
58 N28bdbd22672f40b1a7be68d02f55b425 schema:name doi
59 schema:value 10.1038/clpt.1990.11
60 rdf:type schema:PropertyValue
61 N43de1bed3c674ffa9a62bb991514f88f rdf:first sg:person.0671260531.62
62 rdf:rest N529143f212994efc88d432464a8aa7fa
63 N4d4556916f604964bd13e0a89b833895 schema:name University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center
64 rdf:type schema:Organization
65 N529143f212994efc88d432464a8aa7fa rdf:first sg:person.01303525623.09
66 rdf:rest Nfad557f967be40b1811b8f365485d10b
67 N66ea2ebbf40446ea828bc3c6b4a96d4b schema:name Springer Nature - SN SciGraph project
68 rdf:type schema:Organization
69 N6b6a67c203bf4d7392d4452a8ba9afba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Cystic Fibrosis
71 rdf:type schema:DefinedTerm
72 N6dbd197dbd474e75afb62cb1442347c4 schema:name University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center
73 rdf:type schema:Organization
74 N86e3935c2fe743749df76f732523c4c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Prospective Studies
76 rdf:type schema:DefinedTerm
77 N8876e235f6c2498cb3899eceb6c419a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Penicillins
79 rdf:type schema:DefinedTerm
80 N8c8335c95f754b02ab37757ae3bdc7ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Ticarcillin
82 rdf:type schema:DefinedTerm
83 N996f087638104a83941a0662f9ccc5ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Female
85 rdf:type schema:DefinedTerm
86 Na5f2f1233cb74cd1a28e3c21f3c045f3 schema:name University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center
87 rdf:type schema:Organization
88 Na9e5c4d408de4085908e3a59f7fa62f6 schema:name readcube_id
89 schema:value aca2f56cb04d22363831fa80130641987e542af7d06bfed7cfa419a47229abac
90 rdf:type schema:PropertyValue
91 Naf4eae2cbe2049eb86f94f98f3c22174 schema:name University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center
92 rdf:type schema:Organization
93 Naf6fe96f59eb421a880aee55931c81fe schema:volumeNumber 47
94 rdf:type schema:PublicationVolume
95 Nb08970654629462e8a342111d274ea89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Metabolic Clearance Rate
97 rdf:type schema:DefinedTerm
98 Nb28147f60d5c41768cd21e3c75ca507e schema:name pubmed_id
99 schema:value 2295222
100 rdf:type schema:PropertyValue
101 Nba516bda2d6748149241fcb456bb6910 schema:issueNumber 1
102 rdf:type schema:PublicationIssue
103 Nc0f94e2ed4284a5db1f1ef9d909f6008 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Humans
105 rdf:type schema:DefinedTerm
106 Nc5ebec121afa4ba2877415968ca8ef04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Adolescent
108 rdf:type schema:DefinedTerm
109 Ncd8c85d9501f470baeb0460d6a8f95aa schema:name University of Washington Division of Infectious Disease and the Division of Ambulatory Pediatrics, Children's Hospital and Medical Center
110 rdf:type schema:Organization
111 Nda24dbc038d240deac3bac81a3076e76 rdf:first N2802ea92bcca4fdf877fa55d4e9325a9
112 rdf:rest Nfd2b6d1ba813495fa683881b5863c850
113 Ndc3c8dd407a541f4ada60da54b27bddf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Adult
115 rdf:type schema:DefinedTerm
116 Nf6355e0ad38f41babf31b72f26a58700 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Half-Life
118 rdf:type schema:DefinedTerm
119 Nf6d363eaa15344168fa03626451b91d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Chromatography, High Pressure Liquid
121 rdf:type schema:DefinedTerm
122 Nfad557f967be40b1811b8f365485d10b rdf:first sg:person.01104353520.48
123 rdf:rest rdf:nil
124 Nfd2b6d1ba813495fa683881b5863c850 rdf:first sg:person.01120322662.26
125 rdf:rest N005ad90069c54724b7e075d5f73edf9d
126 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
127 schema:name Medical and Health Sciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
130 schema:name Clinical Sciences
131 rdf:type schema:DefinedTerm
132 sg:journal.1017409 schema:issn 0009-9236
133 1532-6535
134 schema:name Clinical Pharmacology & Therapeutics
135 rdf:type schema:Periodical
136 sg:person.01104353520.48 schema:affiliation N172bd7b7933041cf9ef984a80d9e49b8
137 schema:familyName Smith
138 schema:givenName Arnold L
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104353520.48
140 rdf:type schema:Person
141 sg:person.01120322662.26 schema:affiliation N4d4556916f604964bd13e0a89b833895
142 schema:familyName Hack
143 schema:givenName Barbara D
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120322662.26
145 rdf:type schema:Person
146 sg:person.01303525623.09 schema:affiliation Naf4eae2cbe2049eb86f94f98f3c22174
147 schema:familyName Ramsey
148 schema:givenName Bonnie
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303525623.09
150 rdf:type schema:Person
151 sg:person.0671260531.62 schema:affiliation Na5f2f1233cb74cd1a28e3c21f3c045f3
152 schema:familyName Chaffin
153 schema:givenName Donald
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671260531.62
155 rdf:type schema:Person
156 sg:person.0740433207.38 schema:affiliation Ncd8c85d9501f470baeb0460d6a8f95aa
157 schema:familyName Weber
158 schema:givenName Allan
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740433207.38
160 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...